Muscular Dystrophy (MD) is a group of inherited genetic conditions that cause progressive weakness and degeneration of the muscles that control movement. Over time, the muscles gradually lose strength and mass, making everyday activities such as walking, climbing stairs, lifting objects, or even breathing increasingly difficult.
Muscular dystrophy is a serious and often life-limiting neuromuscular condition. While the severity and progression vary depending on the type, many forms of MD worsen over time as muscle tissue is gradually replaced by fat and connective tissue. Because muscles throughout the body can be affected, the condition may also impact respiratory function, heart health, posture, and mobility.
As the condition progresses, individuals living with muscular dystrophy may experience increasing challenges with independence and day-to-day activities. Many people eventually require assistive devices such as wheelchairs, mobility aids, respiratory support, and other adaptive equipment to maintain comfort, safety, and quality of life.
Beyond the physical impact, muscular dystrophy can also affect emotional wellbeing, education, employment opportunities, and family life. Living with a progressive condition often requires long-term medical care, rehabilitation services, and supportive environments that enable individuals to live with dignity, independence, and inclusion.
Types of Muscular Dystrophy
There are more than 30 types of muscular dystrophy, each caused by specific genetic mutations and affecting different muscle groups. The most common types include:
Duchenne Muscular Dystrophy (DMD) – Duchenne muscular dystrophy is one of the most common and severe forms of MD. It primarily affects boys and usually begins in early childhood, often between the ages of 2 and 5. Children with Duchenne experience progressive muscle weakness, particularly in the hips, thighs, and legs. Over time, many individuals lose the ability to walk and may develop complications affecting the heart and lungs.
Becker Muscular Dystrophy (BMD) – Becker muscular dystrophy is similar to Duchenne but generally progresses more slowly and tends to be less severe. Symptoms often appear during adolescence or early adulthood. Individuals with Becker MD may remain able to walk for many years but may still experience muscle weakness and heart complications.
Limb-Girdle Muscular Dystrophy (LGMD) – Limb-girdle muscular dystrophy affects the muscles around the shoulders and hips. It can develop in childhood or adulthood and varies widely in severity. People with LGMD may have difficulty lifting their arms, climbing stairs, or standing up from a seated position.
Facioscapulohumeral Muscular Dystrophy (FSHD) – This type mainly affects the muscles of the face, shoulders, and upper arms. Symptoms often appear in adolescence or early adulthood. Individuals may experience difficulty smiling, closing their eyes tightly, or raising their arms above shoulder level.
Myotonic Dystrophy – Myotonic dystrophy is one of the most common forms of muscular dystrophy affecting adults. It impacts both muscles and other organs, including the heart, eyes, and endocrine system. A key feature is myotonia, where muscles have difficulty relaxing after contraction.
Congenital Muscular Dystrophy (CMD) – Congenital muscular dystrophy is present at birth or appears in infancy. Babies with this condition may have low muscle tone, delayed motor development, and difficulty with movement or posture. Some forms may also affect brain development.
Emery-Dreifuss Muscular Dystrophy (EDMD) – This rare form of muscular dystrophy affects the muscles in the shoulders, upper arms, and lower legs. It is often associated with joint stiffness (contractures) and heart problems that require careful monitoring.
Spinal Muscular Atrophy – A genetic neuromuscular condition that causes progressive muscle weakness due to the loss of motor neurons in the spinal cord. These motor neurons are responsible for sending signals from the brain to the muscles to control movement. When they deteriorate, the muscles gradually become weak and shrink from lack of use. SMA primarily affects muscles used for movement such as those in the shoulders, hips, thighs, and back, and in more severe cases it can also affect muscles involved in breathing and swallowing. Symptoms may appear in infancy, childhood, or adulthood depending on the type and severity of the condition. People living with SMA may experience difficulties with sitting, standing, walking, or breathing, and many require supportive care such as physiotherapy, respiratory support, mobility aids, and assistive technology. Early diagnosis and multidisciplinary care can significantly improve quality of life and long-term outcomes for individuals living with SMA.
Symptoms, Treatment, Management
Symptoms
The symptoms of muscular dystrophy vary depending on the type and severity of the condition, but they generally involve progressive muscle weakness and loss of muscle mass. Early signs may include difficulty walking, frequent falls, trouble climbing stairs, or difficulty rising from a sitting or lying position. As the condition progresses, individuals may experience muscle stiffness, joint contractures, fatigue, and reduced mobility. In some forms of muscular dystrophy, the muscles involved in breathing and heart function may also be affected, which can lead to respiratory and cardiac complications. The progression and age of onset differ across the various types of muscular dystrophy.
Treatment
There is currently no cure for muscular dystrophy, but treatment focuses on slowing the progression of the condition, managing symptoms, and improving quality of life. Medical care may include medications to help manage muscle degeneration, heart conditions, or inflammation. Regular monitoring by healthcare professionals is important to address complications early. Assistive devices such as braces, mobility aids, and wheelchairs may also be recommended to support independence and safety.
Management
Effective management of muscular dystrophy usually involves a multidisciplinary approach that includes physiotherapy, occupational therapy, respiratory care, and cardiac monitoring. Rehabilitation therapies help maintain muscle strength, prevent complications, and support daily functioning. Assistive technologies, home modifications, and adaptive equipment can improve independence and participation in everyday life. Emotional support, education, and community awareness are also important in helping individuals and families cope with the long-term impact of the condition. Early diagnosis and coordinated care can significantly improve health outcomes and quality of life for people living with muscular dystrophy.
The Challenge in Nigeria
In Nigeria and many parts of Africa, individuals living with MD face significant barriers to diagnosis, treatment, and long-term care. Limited awareness of rare neuromuscular conditions often leads to delayed diagnosis, leaving many children and adults without appropriate medical support.
Access to specialised services such as genetic testing, physiotherapy, occupational therapy, respiratory care, cardiac monitoring, and assistive devices is often limited due to financial constraints. As a result, people living with muscular dystrophy may experience preventable complications and reduced quality of life.
In addition to medical challenges, families frequently face social stigma, discrimination, and financial strain while caring for loved ones with the condition. The lack of structured support systems and inclusive policies further compounds these challenges.
Our Commitment
The Foundation is committed to improving the lives of individuals and families affected by muscular dystrophy through awareness, advocacy, support, and collaboration.
The Foundation works closely with its partner organisation in Nigeria, the Muscular Dystrophy Campaign Nigeria, a local charity dedicated to supporting individuals and families living with muscular dystrophy and other neuromuscular conditions. Through this partnership, we aim to strengthen awareness, improve access to care, and advocate for better support systems for people affected by muscular dystrophy across Nigeria.
Our work focuses on:
- Raising awareness about muscular dystrophy and other neuromuscular conditions
- Promoting early diagnosis and access to medical care
- Supporting individuals and families living with muscular dystrophy
- Advocating for inclusive healthcare and disability policies
- Encouraging research, partnerships, and knowledge sharing
- Strengthening collaboration between organisations in the UK and Nigeria to improve support services
We believe that every individual living with muscular dystrophy deserves access to care, dignity, and the opportunity to live a full and meaningful life.
Through education, advocacy, and partnership, we are working to build a future where people living with muscular dystrophy in Nigeria and beyond receive the support, recognition, and care they deserve.